Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

4.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.9K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

1.9K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.9K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

3.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.9K
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

2.7K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.7K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

3.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.9K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

3.2K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiovascular-Kidney-Metabolic syndrome predicts the development of cardiovascular events in patients with rheumatoid arthritis: a 10-years prospective analysis from the CARMA cohort.

Seminars in arthritis and rheumatism·2026
Same author

Ventricular Tachycardia With a Narrow QRS Complex: When the Improbable Is Possible.

JACC. Case reports·2026
Same author

Lung Function and the GOLD ABE Classification: Do We Need to "Go Back to the Future"?

Open respiratory archives·2026
Same author

Development and Validation of the Risk of Exacerbation in Severe Asthma (RESA) Model.

The journal of allergy and clinical immunology. In practice·2026
Same author

Giant cell arteritis and atherosclerosis: coexistence or causality?

Clinical and experimental rheumatology·2026
Same author

Age-Related Differences in the Clinical Profile and Management of Atrial Fibrillation: Results from the Multicentre REGUEIFA Registry.

Journal of clinical medicine·2026

Related Experiment Video

Updated: Feb 21, 2026

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
06:07

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Published on: October 22, 2020

7.7K

Differences in systemic inflammation between cigarette and biomass smoke-induced COPD.

Rafael Golpe1, Irene Martín-Robles1, Pilar Sanjuán-López1

  • 1Respiratory Medicine Service.

International Journal of Chronic Obstructive Pulmonary Disease
|October 6, 2017
PubMed
Summary
This summary is machine-generated.

Chronic Obstructive Pulmonary Disease (COPD) from tobacco smoke (T-COPD) shows higher systemic inflammation than COPD from biomass smoke (B-COPD). Both conditions elevate inflammatory biomarkers compared to healthy individuals.

Keywords:
COPDbiomass smokecytokinesinflammationsmoking

More Related Videos

Author Spotlight: Development and Characterization of an In Vitro Model to Study Chronic Cigarette Smoke Exposure and Its Impact on Airway Epithelial Cells in COPD Research
09:07

Author Spotlight: Development and Characterization of an In Vitro Model to Study Chronic Cigarette Smoke Exposure and Its Impact on Airway Epithelial Cells in COPD Research

Published on: July 12, 2024

1.9K
Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
10:37

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Published on: January 16, 2015

13.7K

Related Experiment Videos

Last Updated: Feb 21, 2026

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
06:07

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Published on: October 22, 2020

7.7K
Author Spotlight: Development and Characterization of an In Vitro Model to Study Chronic Cigarette Smoke Exposure and Its Impact on Airway Epithelial Cells in COPD Research
09:07

Author Spotlight: Development and Characterization of an In Vitro Model to Study Chronic Cigarette Smoke Exposure and Its Impact on Airway Epithelial Cells in COPD Research

Published on: July 12, 2024

1.9K
Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
10:37

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Published on: January 16, 2015

13.7K

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Environmental Health

Background:

  • Systemic inflammation biomarkers are elevated in tobacco-related COPD (T-COPD) but less is known about biomass-related COPD (B-COPD).
  • Differences in inflammatory profiles between T-COPD and B-COPD are not well understood.

Purpose of the Study:

  • To compare the inflammatory profiles of patients with COPD caused by tobacco smoke versus biomass smoke.
  • To identify specific inflammatory biomarkers that differ between T-COPD and B-COPD.

Main Methods:

  • Matched cohort study comparing 20 T-COPD patients with 20 B-COPD patients (matched for sex, age, FEV1).
  • Included 20 healthy controls.
  • Measured exhaled nitric oxide, serum cytokines (IL-6, IL-8, IL-5, IL-13), periostin, surfactant protein-P, TNF-α, IgE, erythrocyte sedimentation rate, C-reactive protein, fibrinogen, and complete blood count.

Main Results:

  • Both T-COPD and B-COPD groups exhibited higher levels of most inflammatory biomarkers compared to healthy controls.
  • Interleukin-6 (IL-6), IL-8, and IL-5 were significantly elevated in T-COPD compared to B-COPD.
  • No other significant differences in measured inflammatory biomarkers were found between T-COPD and B-COPD.

Conclusions:

  • Both tobacco smoke and biomass smoke-induced COPD are characterized by elevated systemic inflammation.
  • Patients with T-COPD demonstrate a more pronounced systemic inflammatory status compared to patients with B-COPD.